Agomelatine as a novel treatment option in panic disorder, results from an 8-week open-label trial

K.M.L. Huijbregts, N.M. Batelaan, J. Schonenberg, G. Veen, A.J.L.M. van Balkom

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

Original language	English
Pages (from-to)	336-338
Journal	Journal of clinical psychopharmacology
Volume	35
Issue number	3
DOIs	https://doi.org/10.1097/JCP.0000000000000313
Publication status	Published - 2015

Access to Document

@article{22bcb20f20dd475082d898883579510b,

title = "Agomelatine as a novel treatment option in panic disorder, results from an 8-week open-label trial",

author = "K.M.L. Huijbregts and N.M. Batelaan and J. Schonenberg and G. Veen and {van Balkom}, A.J.L.M.",

year = "2015",

doi = "https://doi.org/10.1097/JCP.0000000000000313",

language = "English",

volume = "35",

pages = "336--338",

journal = "Journal of clinical psychopharmacology",

issn = "0271-0749",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Agomelatine as a novel treatment option in panic disorder, results from an 8-week open-label trial

AU - Huijbregts, K.M.L.

AU - Batelaan, N.M.

AU - Schonenberg, J.

AU - Veen, G.

AU - van Balkom, A.J.L.M.

PY - 2015

Y1 - 2015

U2 - https://doi.org/10.1097/JCP.0000000000000313

DO - https://doi.org/10.1097/JCP.0000000000000313

M3 - Article

C2 - 25856784

SN - 0271-0749

VL - 35

SP - 336

EP - 338

JO - Journal of clinical psychopharmacology

JF - Journal of clinical psychopharmacology

IS - 3

ER -